Treatment-free remission following frontline nilotinib in patients with chronic phase chronic myeloid leukemia: 5-year update of the ENESTfreedom trial
Leukemia, Published online: 11 March 2021; doi:10.1038/s41375-021-01205-5Treatment-free remission following frontline nilotinib in patients with chronic phase chronic myeloid leukemia: 5-year update of the ENESTfreedom trial
Source: Leukemia - Category: Hematology Authors: Jerald P. Radich Andreas Hochhaus Tam ás Masszi Andrzej Hellmann Jesper Stentoft Mar ía Teresa Gómez Casares J. Valent ín García-Gutiérrez Eibhlin Conneally Philipp D. le Coutre Norbert Gattermann Bruno Martino Susanne Saussele Francis J. Giles Davi Source Type: research
More News: Chronic Leukemia | Chronic Myeloid Leukaemia | Hematology | Leukemia | Nilotinib | Tasigna